ATE229326T1 - Therapie von depressionen - Google Patents

Therapie von depressionen

Info

Publication number
ATE229326T1
ATE229326T1 AT99921726T AT99921726T ATE229326T1 AT E229326 T1 ATE229326 T1 AT E229326T1 AT 99921726 T AT99921726 T AT 99921726T AT 99921726 T AT99921726 T AT 99921726T AT E229326 T1 ATE229326 T1 AT E229326T1
Authority
AT
Austria
Prior art keywords
therapy
depression
antidepressant
delivering
patient
Prior art date
Application number
AT99921726T
Other languages
English (en)
Inventor
Atul D Ayer
Sylvia Seroff
Patrick S-L Wong
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE229326T1 publication Critical patent/ATE229326T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT99921726T 1998-05-14 1999-05-07 Therapie von depressionen ATE229326T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8543298P 1998-05-14 1998-05-14
PCT/US1999/009917 WO1999058115A1 (en) 1998-05-14 1999-05-07 Antidepressant therapy

Publications (1)

Publication Number Publication Date
ATE229326T1 true ATE229326T1 (de) 2002-12-15

Family

ID=22191553

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99921726T ATE229326T1 (de) 1998-05-14 1999-05-07 Therapie von depressionen

Country Status (11)

Country Link
US (1) US20010055614A1 (de)
EP (1) EP1077683B1 (de)
JP (1) JP2002514592A (de)
AT (1) ATE229326T1 (de)
AU (1) AU3885799A (de)
CA (1) CA2331542A1 (de)
DE (1) DE69904465T2 (de)
DK (1) DK1077683T3 (de)
ES (1) ES2187156T3 (de)
PT (1) PT1077683E (de)
WO (1) WO1999058115A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0707127D0 (en) * 2007-04-13 2007-05-23 Zysis Ltd Pharmaceutical compositions
SMT201700578T1 (it) 2009-11-20 2018-01-11 Tonix Pharma Holdings Ltd Metodo e composizioni per trattare i sintomi associati al disturbo da stress post-traumatico usando ciclobenzaprina
EP2555751B8 (de) * 2010-04-03 2018-02-14 Praful Doshi Verfahren zum beschichtigen von einer kontaktlinse
US20110319389A1 (en) 2010-06-24 2011-12-29 Tonix Pharmaceuticals, Inc. Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US11998516B2 (en) 2011-03-07 2024-06-04 Tonix Pharma Holdings Limited Methods and compositions for treating depression using cyclobenzaprine
LT2861223T (lt) * 2012-06-15 2022-12-12 Tonix Pharma Holdings Limited Kompozicijos ir būdai, skirti absorbavimui per gleivinę
NZ631152A (en) 2013-03-15 2017-05-26 Tonix Pharmaceuticals Inc Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
WO2015085312A1 (en) * 2013-12-06 2015-06-11 Durect Corporation Compositions comprising antioxidant, fluid dispensers, and methods involving the same
EP3193854A4 (de) 2014-09-18 2018-05-02 Tonix Pharma Holdings Limited Eutektische formulierungen von cyclobenzaprin-hydrochlorid
CA3083341C (en) 2017-12-11 2024-05-28 Tonix Pharma Holdings Limited Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
US5591454A (en) * 1989-09-05 1997-01-07 Alza Corporation Method for lowering blood glucose
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
EP0640341A1 (de) * 1993-08-27 1995-03-01 Mitsui Toatsu Chemicals, Incorporated Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren

Also Published As

Publication number Publication date
WO1999058115A1 (en) 1999-11-18
EP1077683A1 (de) 2001-02-28
ES2187156T3 (es) 2003-05-16
JP2002514592A (ja) 2002-05-21
DE69904465D1 (de) 2003-01-23
DK1077683T3 (da) 2003-03-31
EP1077683B1 (de) 2002-12-11
US20010055614A1 (en) 2001-12-27
PT1077683E (pt) 2003-04-30
DE69904465T2 (de) 2003-10-02
AU3885799A (en) 1999-11-29
CA2331542A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
CY1118206T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
DK1035834T3 (da) Osmotisk doseringsform omfattende en første og anden coating
PT913156E (pt) Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
DK0546038T3 (da) Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse
FI924352A0 (fi) Jontoforetiskt laekemedels frigoeringssystem.
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
DE69814394D1 (de) Verwendung von levobupivacain
ATE249238T1 (de) Verwendung von thrombin-derivierten peptiden zur therapie von kardiovaskuläre krankheiten
PT946151E (pt) Forma de dosagem de dose crescente
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
ATE229326T1 (de) Therapie von depressionen
DE60019334D1 (de) Antivirale arznei
ATE210429T1 (de) Therapie mittels gleichförmiger arzneistoffverabreichung
PT981347E (pt) Utilizacao de levobupivacaina em cirurgia facial
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
SE9601395D0 (sv) New therapeutic treatment 1
SE9902597D0 (sv) New use
TR200401810T4 (tr) Kısırlık tedavisinde fsh'ın kullanılması
ATE293972T1 (de) Behandlung von chronischen schmerzen
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1077683

Country of ref document: EP

REN Ceased due to non-payment of the annual fee